BIOGEN INC (IDP.DE) Fundamental Analysis & Valuation
FRA:IDP • US09062X1037
Current stock price
164.54 EUR
+2.14 (+1.32%)
Last:
This IDP.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. IDP.DE Profitability Analysis
1.1 Basic Checks
- In the past year IDP was profitable.
- In the past year IDP had a positive cash flow from operations.
- Each year in the past 5 years IDP has been profitable.
- In the past 5 years IDP always reported a positive cash flow from operatings.
1.2 Ratios
- IDP has a better Return On Assets (4.39%) than 77.78% of its industry peers.
- IDP's Return On Equity of 7.08% is fine compared to the rest of the industry. IDP outperforms 79.01% of its industry peers.
- The Return On Invested Capital of IDP (8.93%) is better than 82.72% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for IDP is below the industry average of 12.00%.
- The last Return On Invested Capital (8.93%) for IDP is above the 3 year average (8.93%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.39% | ||
| ROE | 7.08% | ||
| ROIC | 8.93% |
ROA(3y)4.85%
ROA(5y)6.69%
ROE(3y)8.23%
ROE(5y)12.34%
ROIC(3y)8.93%
ROIC(5y)10.93%
1.3 Margins
- Looking at the Profit Margin, with a value of 13.07%, IDP is in the better half of the industry, outperforming 79.01% of the companies in the same industry.
- IDP's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 27.94%, IDP belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
- IDP's Operating Margin has declined in the last couple of years.
- IDP has a better Gross Margin (75.69%) than 66.67% of its industry peers.
- IDP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.94% | ||
| PM (TTM) | 13.07% | ||
| GM | 75.69% |
OM growth 3Y-3.78%
OM growth 5Y-5.27%
PM growth 3Y-24.15%
PM growth 5Y-15.17%
GM growth 3Y-0.7%
GM growth 5Y-2.57%
2. IDP.DE Health Analysis
2.1 Basic Checks
- IDP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- IDP has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, IDP has less shares outstanding
- IDP has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 3.35 indicates that IDP is not in any danger for bankruptcy at the moment.
- IDP's Altman-Z score of 3.35 is in line compared to the rest of the industry. IDP outperforms 59.26% of its industry peers.
- IDP has a debt to FCF ratio of 3.11. This is a good value and a sign of high solvency as IDP would need 3.11 years to pay back of all of its debts.
- IDP has a Debt to FCF ratio of 3.11. This is amongst the best in the industry. IDP outperforms 85.19% of its industry peers.
- A Debt/Equity ratio of 0.34 indicates that IDP is not too dependend on debt financing.
- IDP has a Debt to Equity ratio (0.34) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 3.11 | ||
| Altman-Z | 3.35 |
ROIC/WACC0.97
WACC9.22%
2.3 Liquidity
- A Current Ratio of 2.68 indicates that IDP has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 2.68, IDP is in line with its industry, outperforming 53.09% of the companies in the same industry.
- A Quick Ratio of 2.03 indicates that IDP has no problem at all paying its short term obligations.
- With a Quick ratio value of 2.03, IDP perfoms like the industry average, outperforming 50.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.68 | ||
| Quick Ratio | 2.03 |
3. IDP.DE Growth Analysis
3.1 Past
- The earnings per share for IDP have decreased by -7.16% in the last year.
- IDP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.17% yearly.
- IDP shows a small growth in Revenue. In the last year, the Revenue has grown by 2.22%.
- Measured over the past years, IDP shows a decrease in Revenue. The Revenue has been decreasing by -5.96% on average per year.
EPS 1Y (TTM)-7.16%
EPS 3Y-6.07%
EPS 5Y-14.17%
EPS Q2Q%-42.15%
Revenue 1Y (TTM)2.22%
Revenue growth 3Y-0.93%
Revenue growth 5Y-5.96%
Sales Q2Q%-7.14%
3.2 Future
- IDP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.53% yearly.
- The Revenue is expected to decrease by -0.48% on average over the next years.
EPS Next Y5.45%
EPS Next 2Y3.4%
EPS Next 3Y3.98%
EPS Next 5Y3.53%
Revenue Next Year-3.54%
Revenue Next 2Y-1.96%
Revenue Next 3Y-0.91%
Revenue Next 5Y-0.48%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. IDP.DE Valuation Analysis
4.1 Price/Earnings Ratio
- IDP is valuated correctly with a Price/Earnings ratio of 12.63.
- IDP's Price/Earnings ratio is rather cheap when compared to the industry. IDP is cheaper than 92.59% of the companies in the same industry.
- When comparing the Price/Earnings ratio of IDP to the average of the S&P500 Index (27.47), we can say IDP is valued rather cheaply.
- With a Price/Forward Earnings ratio of 11.97, the valuation of IDP can be described as very reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of IDP indicates a rather cheap valuation: IDP is cheaper than 97.53% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 22.62, IDP is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.63 | ||
| Fwd PE | 11.97 |
4.2 Price Multiples
- 90.12% of the companies in the same industry are more expensive than IDP, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of IDP indicates a rather cheap valuation: IDP is cheaper than 97.53% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.03 | ||
| EV/EBITDA | 8.36 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- IDP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.32
PEG (5Y)N/A
EPS Next 2Y3.4%
EPS Next 3Y3.98%
5. IDP.DE Dividend Analysis
5.1 Amount
- No dividends for IDP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IDP.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:IDP (4/23/2026, 10:39:17 AM)
164.54
+2.14 (+1.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-06 2026-02-06/bmo
Earnings (Next)04-29 2026-04-29
Inst Owners98.03%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap24.15B
Revenue(TTM)9.89B
Net Income(TTM)1.29B
Analysts73.02
Price Target183.33 (11.42%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.18%
Min EPS beat(2)20.87%
Max EPS beat(2)21.48%
EPS beat(4)4
Avg EPS beat(4)24.64%
Min EPS beat(4)17.28%
Max EPS beat(4)38.92%
EPS beat(8)8
Avg EPS beat(8)17.2%
EPS beat(12)12
Avg EPS beat(12)12.76%
EPS beat(16)15
Avg EPS beat(16)12.81%
Revenue beat(2)2
Avg Revenue beat(2)3.75%
Min Revenue beat(2)1.26%
Max Revenue beat(2)6.23%
Revenue beat(4)4
Avg Revenue beat(4)6.45%
Min Revenue beat(4)1.26%
Max Revenue beat(4)11.62%
Revenue beat(8)6
Avg Revenue beat(8)2.98%
Revenue beat(12)9
Avg Revenue beat(12)2.26%
Revenue beat(16)11
Avg Revenue beat(16)1.92%
PT rev (1m)3.56%
PT rev (3m)12.35%
EPS NQ rev (1m)-2.21%
EPS NQ rev (3m)-15.11%
EPS NY rev (1m)0.27%
EPS NY rev (3m)4.3%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)1.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.63 | ||
| Fwd PE | 11.97 | ||
| P/S | 2.86 | ||
| P/FCF | 14.03 | ||
| P/OCF | 12.85 | ||
| P/B | 1.55 | ||
| P/tB | 10.95 | ||
| EV/EBITDA | 8.36 |
EPS(TTM)13.03
EY7.92%
EPS(NY)13.74
Fwd EY8.35%
FCF(TTM)11.73
FCFY7.13%
OCF(TTM)12.8
OCFY7.78%
SpS57.44
BVpS106.02
TBVpS15.03
PEG (NY)2.32
PEG (5Y)N/A
Graham Number176.306 (7.15%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.39% | ||
| ROE | 7.08% | ||
| ROCE | 10.59% | ||
| ROIC | 8.93% | ||
| ROICexc | 10.46% | ||
| ROICexgc | 35.29% | ||
| OM | 27.94% | ||
| PM (TTM) | 13.07% | ||
| GM | 75.69% | ||
| FCFM | 20.42% |
ROA(3y)4.85%
ROA(5y)6.69%
ROE(3y)8.23%
ROE(5y)12.34%
ROIC(3y)8.93%
ROIC(5y)10.93%
ROICexc(3y)9.96%
ROICexc(5y)13.03%
ROICexgc(3y)38.5%
ROICexgc(5y)36.85%
ROCE(3y)10.59%
ROCE(5y)12.95%
ROICexgc growth 3Y4.85%
ROICexgc growth 5Y-4.35%
ROICexc growth 3Y-13.95%
ROICexc growth 5Y-14.37%
OM growth 3Y-3.78%
OM growth 5Y-5.27%
PM growth 3Y-24.15%
PM growth 5Y-15.17%
GM growth 3Y-0.7%
GM growth 5Y-2.57%
F-Score4
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 3.11 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 23.77% | ||
| Cap/Sales | 1.87% | ||
| Interest Coverage | 10.46 | ||
| Cash Conversion | 62.22% | ||
| Profit Quality | 156.18% | ||
| Current Ratio | 2.68 | ||
| Quick Ratio | 2.03 | ||
| Altman-Z | 3.35 |
F-Score4
WACC9.22%
ROIC/WACC0.97
Cap/Depr(3y)46.72%
Cap/Depr(5y)49.51%
Cap/Sales(3y)2.92%
Cap/Sales(5y)2.77%
Profit Quality(3y)138.91%
Profit Quality(5y)133.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.16%
EPS 3Y-6.07%
EPS 5Y-14.17%
EPS Q2Q%-42.15%
EPS Next Y5.45%
EPS Next 2Y3.4%
EPS Next 3Y3.98%
EPS Next 5Y3.53%
Revenue 1Y (TTM)2.22%
Revenue growth 3Y-0.93%
Revenue growth 5Y-5.96%
Sales Q2Q%-7.14%
Revenue Next Year-3.54%
Revenue Next 2Y-1.96%
Revenue Next 3Y-0.91%
Revenue Next 5Y-0.48%
EBIT growth 1Y8.4%
EBIT growth 3Y-4.68%
EBIT growth 5Y-10.91%
EBIT Next Year17.07%
EBIT Next 3Y5.07%
EBIT Next 5Y1.28%
FCF growth 1Y-19.74%
FCF growth 3Y20.95%
FCF growth 5Y-11.3%
OCF growth 1Y-23.33%
OCF growth 3Y16.78%
OCF growth 5Y-12.22%
BIOGEN INC / IDP.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of BIOGEN INC (IDP.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to IDP.DE.
What is the valuation status for IDP stock?
ChartMill assigns a valuation rating of 7 / 10 to BIOGEN INC (IDP.DE). This can be considered as Undervalued.
How profitable is BIOGEN INC (IDP.DE) stock?
BIOGEN INC (IDP.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for IDP stock?
The Price/Earnings (PE) ratio for BIOGEN INC (IDP.DE) is 12.63 and the Price/Book (PB) ratio is 1.55.
What is the earnings growth outlook for BIOGEN INC?
The Earnings per Share (EPS) of BIOGEN INC (IDP.DE) is expected to grow by 5.45% in the next year.